Cavity and 
sentinel lymph node marking 412 devices, marker delivery devices, and methods are disclosed. More particularly, upon 
insertion into a body, the cavity marking device and method enable one to determine the center, orientation, and periphery of the cavity by radiographic, 
mammography, echogenic, or other noninvasive imaging techniques. A composition and method are disclosed for locating the 
sentinel lymph node in a mammalian body to determine if cancerous cells have spread thereto. The composition is preferably a 
fluid composition consisting of a 
carrier fluid and some type of contrast agent; alternatively, the contrast agent may itself be a fluid and therefore not need a separate 
carrier fluid. This composition is capable of (1) deposition in or around a 
lesion and migration to and accumulation in the associated 
sentinel node, and (2) 
remote detection via any number of noninvasive techniques. Also disclosed is a method for remotely detecting the location of a 
sentinel node by (1) depositing a remotely detectable fluid in or around a 
lesion for migration to and accumulation in the associated 
sentinel node and (2) remotely detecting the location of that node with a minimum of trauma and 
toxicity to the patient. The composition and method may serve to mark a 
biopsy cavity, as well as mark the 
sentinel lymph node. The marking methods also may combine any of the features as described with the marking device and delivery device.